- Conditions
- Plaque Psoriasis
- Interventions
- DFD01 Spray
- Drug
- Lead sponsor
- Primus Pharmaceuticals
- Industry
- Eligibility
- 12 Years to 16 Years
- Enrollment
- 3 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2019
- U.S. locations
- 8
- States / cities
- Encino, California • Irvine, California • San Diego, California + 5 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–6
of 6
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Psoriasis
- Interventions
- Ruxolitinib phosphate cream, Dovonex® calcipotriene 0.005%, Diprolene® AF betamethasone dipropionate 0.05% cream., Placebo cream
- Drug
- Lead sponsor
- Incyte Corporation
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 29 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 6
- States / cities
- Vallejo, California • Boston, Massachusetts • Rochester, New York + 3 more
- Conditions
- Plaque Psoriasis
- Interventions
- DFD-01 (betamethasone dipropionate) Spray, 0.05%
- Drug
- Lead sponsor
- Primus Pharmaceuticals
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 45 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016
- U.S. locations
- 4
- States / cities
- Arlington Heights, Illinois • New Albany, Indiana • Louisville, Kentucky + 1 more
- Conditions
- Plaque Psoriasis
- Interventions
- DFD01 Spray, Comp01 Lotion
- Drug
- Lead sponsor
- Primus Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 75 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014
- U.S. locations
- 12
- States / cities
- Encinitas, California • Encino, California • Santa Rosa, California + 8 more
- Conditions
- Plaque Psoriasis
- Interventions
- Clobetasol Propionate, 0.05%, Calcipotriene and betamethasone dipropionate ointment
- Drug
- Lead sponsor
- Galderma R&D
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 122 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 4
- States / cities
- Fridley, Minnesota • Austin, Texas • Bryan, Texas + 1 more
- Conditions
- ICD10 Code L40.9 for Psoriasis
- Interventions
- Betamethasone dipropionate 0.05%, Tapinarof
- Drug
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- Winston-Salem, North Carolina